These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1378260)

  • 41. Holmium laser prostatic resection for patients presenting with acute urinary retention.
    Anderson CB; Helfand BT; McVary KT
    BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
    Zhao Z; Wang G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy.
    Doll HA; Black NA; McPherson K; Flood AB; Williams GB; Smith JC
    J Urol; 1992 Jun; 147(6):1566-73. PubMed ID: 1375662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benign prostatic hyperplasia.
    Bruskewitz R
    J Urol; 1997 Jul; 158(1):100-1. PubMed ID: 9186332
    [No Abstract]   [Full Text] [Related]  

  • 45. Symptom status and quality of life following prostatectomy.
    Fowler FJ; Wennberg JE; Timothy RP; Barry MJ; Mulley AG; Hanley D
    JAMA; 1988 May; 259(20):3018-22. PubMed ID: 2452905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regional variation in intervention rates: what are the implications for patient selection?
    Black N; Griffiths J; Glickman ME
    J Public Health Med; 1997 Sep; 19(3):274-80. PubMed ID: 9347450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult progressive renal damage in the elderly male due to benign prostatic hypertrophy.
    Mukamel E; Nissenkorn I; Boner G; Servadio C
    J Am Geriatr Soc; 1979 Sep; 27(9):403-6. PubMed ID: 89133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between haemorrhoids and prostatism: results of a prospective study.
    Akande B; Esho JO
    Eur Urol; 1989; 16(5):333-4. PubMed ID: 2476316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative evaluation of prostatectomy for benign prostatic hypertrophy under a national health insurance law: a multi-centre study.
    Pilpel D; Porath A; Peleg A
    J Eval Clin Pract; 2002 Feb; 8(1):9-18. PubMed ID: 11882097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benign prostatic hypertrophy and uraemia. A review of 315 cases.
    Beck AD
    Br J Surg; 1970 Aug; 57(8):561-5. PubMed ID: 4194997
    [No Abstract]   [Full Text] [Related]  

  • 51. Criterion validation of the Nottingham Health Profile: patient views of surgery for benign prostatic hypertrophy.
    Doll HA; Black NA; Flood AB; McPherson K
    Soc Sci Med; 1993 Jul; 37(1):115-22. PubMed ID: 7687383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous urography pre prostatectomy: an evaluation of its use.
    Hamed AD; Kehinde EO
    Afr J Med Med Sci; 1993 Sep; 22(3):93-6. PubMed ID: 7530901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Appropriate indications for prostatectomy in the UK--results of a consensus panel.
    Hunter DJ; McKee CM; Sanderson CF; Black NA
    J Epidemiol Community Health; 1994 Feb; 48(1):58-64. PubMed ID: 7511156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of expectations in patients' reports of post-operative outcomes and improvement following therapy.
    Flood AB; Lorence DP; Ding J; McPherson K; Black NA
    Med Care; 1993 Nov; 31(11):1043-56. PubMed ID: 7694013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-dimensional outcome analysis as a guide for quality assurance of prostatectomy.
    Cohen YC; Olmer L; Mozes B
    Int J Qual Health Care; 1996 Feb; 8(1):67-73. PubMed ID: 8680819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hard measures of subjective outcomes: validating symptom indexes in urology.
    O'Leary MP; Barry MJ; Fowler FJ
    J Urol; 1992 Nov; 148(5):1546-8; discussion 1564. PubMed ID: 1279217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of prolactin in benign prostatic hypertrophy.
    Birkhoff JD; Lattimer JK; Frantz AG
    Urology; 1974 Nov; 4(5):557-9. PubMed ID: 4139796
    [No Abstract]   [Full Text] [Related]  

  • 58. International variation in intervention rates. What are the implications for patient selection?
    Black N; Glickman ME; Ding J; Flood AB
    Int J Technol Assess Health Care; 1995; 11(4):719-32. PubMed ID: 8567204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Iliac artery embolism preventing bleeding in prostatectomy].
    BRETON PLANDIURA M
    Arch Esp Urol; 1953 Apr; 9(2):159-63. PubMed ID: 13105542
    [No Abstract]   [Full Text] [Related]  

  • 60. Preoperative clinical condition and postoperative course in prostatic hypertrophy.
    HASNER E
    Dan Med Bull; 1962 Jun; 9():80-2. PubMed ID: 13905245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.